Onconova Therapeutics
NASDAQ: TRAWNewtown, US · Delaware corporation
Biotech
Founders & leadership
RK
Ramesh Kumar, Ph.DCo-founder
EP
E. Premkumar ReddyCo-founder
MM
Manoj ManiarExecutive
TM
Thomas McKearnExecutive
AB
Ajay BansalExecutive
SF
Steven FruchtmanExecutive
Board
MH
Michael HoffmanBoard director
VM
Viren MehtaBoard director
AM
Anne M. VanLentBoard director
HS
Henry S BienenBoard director
JM
James MarinoBoard director
JE
Jerome E. GroopmanBoard director
Reported raises · per SEC filings
Form D private placements$17.3M disclosed across 4 rounds · 2015–2024
▶$14MraisedApr 2024 · 2 investors · BiotechnologyRule 506(b)
▶$14MraisedApr 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- M. Theresa ShoemakerDirector
- Jack E. StoverDirector
- Trafford ClarkeDirector
- Nikolay SavchukDirector, Executive Officer
- Ian DukesDirector
- David PauzaExecutive Officer
- Robert RedfieldExecutive Officer
- Mark GuerinExecutive Officer
- Steven FruchtmanExecutive Officer
- Werner CautreelsDirector, Executive Officer
- James MarinoDirector
- Offering amount
- $14M
- Amount sold
- $14M
- Sales commissions
- $1M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJun 2019 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedJun 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael B. HoffmanDirector
- Jerome E. GroopmanDirector
- Abraham N. OlerExecutive Officer
- Viren MehtaDirector
- James J. MarinoDirector
- Premkumar ReddyDirector
- Jack E. StoverDirector
- Steven M. FruchtmanExecutive Officer, Director
- Manoj ManiarExecutive Officer
- Mark P. GuerinExecutive Officer
- Richard C. WoodmanExecutive Officer
- Offering amount
- $2M
- Amount sold
- $500K
- Minimum investment
- $500K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedJun 2018 · 1 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael B. HoffmanDirector
- Jerome E. GroopmanDirector
- Mark P. GuerinExecutive Officer
- Jack E. StoverDirector
- Ramesh KumarExecutive Officer, Director
- Manoj ManiarExecutive Officer
- E. Premkumar ReddyDirector
- Steven M. FruchtmanExecutive Officer
- Henry S. BienenDirector
- James J. MarinoDirector
- Viren MehtaDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Minimum investment
- $1.3M
- Sales commissions
- $75K
- Placement agents
- Lucas Advisors LLC d/b/a KYBORA Emerging Markets
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedOct 2015 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedOct 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Manoj ManiarExecutive Officer
- Thomas McKearnExecutive Officer
- Ajay BansalExecutive Officer
- Anne M. VanLentDirector
- Henry S BienenDirector
- Ramesh Kumar, Ph.DExecutive Officer, Director
- E. Premkumar ReddyDirector
- James MarinoDirector
- Jerome E. GroopmanDirector
- Michael HoffmanDirector
- Viren MehtaDirector
- Steven FruchtmanExecutive Officer
- Offering amount
- $16.5M
- Amount sold
- $1.5M
- Minimum investment
- $1.5M
- Proceeds to insiders
- $100K
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Onconova Therapeutics?
- Onconova Therapeutics was founded by Ramesh Kumar, Ph.D, E. Premkumar Reddy.
- How much funding has Onconova Therapeutics raised?
- Onconova Therapeutics has disclosed $17.3M raised across 4 rounds.
- Where is Onconova Therapeutics headquartered?
- Onconova Therapeutics is headquartered in Newtown, US.